LATEST
There are no tropical cyclones at this time.✦AP Liquor Scam: SC Court Pulls Up SIT Over Probe, Issues Notices To Raj Kasireddy✦31/22:27 EST Severe Weather Warning for parts of Snowy Mountains Forecast District. ✦Samudra Manthan Scheme Devised To Benefit Adani, Must Be Scrapped: Congress✦SC To Hear Centre's Plea To Quash FIRs Against NEET Protesters✦
Mon, Aug 31, 2026
Loading weather...
Business

H.C. Wainwright reiterates CRISPR Therapeutics stock rating at buy

By Dhallo News · August 31, 2026 at 5:12 PM IST
H.C. Wainwright reiterates CRISPR Therapeutics stock rating at buy
Source: Investing.com - News

More details on this developing story will follow.

Original reporting: Investing.com - NewsRead original report →
Have feedback on this article?Report error or suggestion

Read More from Business

Crude oil jumps more than 3% as Middle East fighting flares

Breaking News......

Read Article »

India’s PE/VC investments rise 52% in July to $4.1 billion

Large transactions accounted for 68% of July’s investment activity, while infras...

Read Article »

Majestic Gold declares CAD 0.0055 special cash dividend

Breaking News......

Read Article »
Return to Front Page

Subscribe to Our Newsletter

Get the latest breaking news and top stories delivered straight to your inbox.